Financials and Corporate
Innate Pharma obtains ISO9001:2000 certification for its research and development activities in the field of immunotherapy
This certification marks a new milestone in the maturation of the company, obtained at a time when Innate Pharma is significantly building up its team, enlarging its portfolio of compounds and working...
Innate Pharma welcomes Dr. Squiban as Chief Medical Officer
Dr. Squiban, 53, joined Innate Pharma after eight years at Transgene (1997-2005), a French company dedicated to the discovery and development of therapeutic vaccines and gene therapy products, as...
Relations investisseurs
Inscrivez-vous à notre newsletter, suivez-nous sur twitter et sur linkedin
Relations investisseurs
Adresse : 117, Avenue de Luminy - BP 30191, 13 009 Marseille FRANCE
Tél. : +33 (0)4 30 30 30 87
Fax : +33 (0)4 30 30 30 00
Financial calendar for 2008 and update on next meetings with analysts and investors
Innate Pharma SA announced today announced its tentative financial and investor relations calendar for 2008. The Company updated on its next meetings with analysts and investors.
Turnover of 5.1 million euros for the first nine months of 2007
Innate Pharma SA announced a turnover of 5.1 million euros for the first nine months of 2007.